Perrigo (PRGO +0.7%) says it's initiated preliminary shipments of its Guaifenesin Extended-Release Tablets, a generic version of Mucinex, to a select number of customers. The company expects to initiate its full-scale over-the-counter launch to its retail and wholesale customers in before the end of its current fiscal year.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs